Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses
Aus Alzaid, Patricia Ladrón de Guevara, Maud Beillat, Valérie Lehner Martin, Petar Atanasov
Abstract
The burden of T2D, related complications and inherent costs are higher in emerging versus established market countries. This review explores potential strategies to reduce costs and enhance outcomes of T2D treatment in developing countries.
Topics & Concepts
MedicineType 2 diabetesGlycemicIntensive care medicineDiseaseMEDLINEType 2 Diabetes MellitusDisease burdenEpidemiologyIndirect costsDiabetes mellitusEnvironmental healthInternal medicineBusinessEndocrinologyPolitical scienceLawAccountingDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementDiabetes Management and Research